Cure of myeloma: hype or reality?
- 15 November 2004
- journal article
- review article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 35 (3) , 215-224
- https://doi.org/10.1038/sj.bmt.1704757
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- A Phase 2 Study of Bortezomib in Relapsed, Refractory MyelomaNew England Journal of Medicine, 2003
- Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human Erythropoietin, Epoetin Beta, in Hematologic MalignanciesJournal of Clinical Oncology, 2002
- Kyphoplasty in the Treatment of Osteolytic Vertebral Compression Fractures as a Result of Multiple MyelomaJournal of Clinical Oncology, 2002
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.Journal of Clinical Oncology, 1998
- Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up.Radiology, 1996
- Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple MyelomaNew England Journal of Medicine, 1996
- VAD‐based regimens as primary treatment for multiple myelomaAmerican Journal of Hematology, 1990
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMAThe Lancet, 1983